Neuland Laboratories Limited (BOM:524558)
15,208
-94 (-0.61%)
At close: Apr 20, 2026
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 195.12 billion as of April 20, 2026. Its market cap has increased by 34.95% in one year.
Market Cap
195.12B
Enterprise Value
196.07B
Revenue
15.75B
Ranking
n/a
PE Ratio
108.92
Stock Price
15,207.90
Market Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 195.12B, an increase of 58,119.23%. That is a compound annual growth rate of 28.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 195.12B | 0.12% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shilpa Medicare | 80.49B |
| Suven Life Sciences | 51.66B |
| Gujarat Themis Biosyn | 34.81B |
| IOL Chemicals and Pharmaceuticals | 26.76B |
| Sai Parenteral's | 21.21B |
| NGL Fine-Chem | 13.78B |
| Bajaj HealthCare | 10.54B |
| Anlon Healthcare | 7.54B |